SINO BIOPHARM Reports 12.3% Increase in Interim Net Profit to RMB3.389 Billion; Interim Dividend Per Share Reaches HKD5 Cents
Company Performance: SINO BIOPHARM reported interim results for the six months ending June 30, 2025, with revenue of RMB17.575 billion, reflecting a 10.7% year-over-year increase.
Profit Growth: The net profit for the period rose by 12.3% year-over-year to RMB3.389 billion, resulting in earnings per share (EPS) of RMB18.82 cents.
Dividend Announcement: The company declared an interim dividend per share (DPS) of HKD5 cents, up from HKD3 cents during the same period last year.
Market Activity: Short selling activity reached $256.35 million, with a short selling ratio of 22.279%.
Trade with 70% Backtested Accuracy
Analyst Views on 01177
About the author
<Study>UBS Ratings and Price Targets for Pharmaceutical Companies (Table)
Stock Performance: Several pharmaceutical stocks showed mixed performance, with HENGRUI PHARMA and HANSOH PHARMA experiencing gains, while SINO BIOPHARM saw a decline.
Short Selling Data: Short selling activity varied across companies, with SINO BIOPHARM having the highest short selling amount at $180.02M and a ratio of 40.682%.
Target Prices: Analysts have set target prices for various stocks, with HENGRUI PHARMA and HANSOH PHARMA rated as "Buy" with target prices of HK$98.3 and HK$51.5, respectively.
Market Sentiment: CSPC PHARMA received a "Neutral" rating, indicating a more cautious outlook compared to the "Buy" ratings for other companies listed.
HSI Closes Down 384 Points on Futures Settlement Day; Declines in Tech, Auto, Consumer, and Pharma Sectors
Hong Kong Stock Market Performance: The Hong Kong stock market opened higher but closed lower, with the HSI down 384 points (1.4%) at 26,381, and total market turnover at HKD259.277 billion.
CKI Holdings' Stock Surge: A consortium led by CKI Holdings sold UKPN, resulting in a 4.5% increase in its stock price, while CKH Holdings and Power Assets also saw significant gains.
Tech Sector Declines: Alibaba's stock fell 3.6% after a report predicted weak quarterly profits, while other tech stocks like Tencent and Meituan also experienced declines.
Pharmaceuticals and Consumer Stocks Drop: Various pharmaceutical and consumer stocks saw significant losses, with declines ranging from 3.3% to 9.2% across multiple companies.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
<Full-day Summary> HSI Falls by 491 Points; HSTI Declines by 114 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, MTR CORPORATION, SINOPHARM Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 491 points (1.8%) to close at 26,590, with significant declines also seen in the HSTI and HSCEI, which dropped 114 points (2.1%) and 189 points (2.1%) respectively, amid a market turnover of $250.99 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi experienced notable declines, with Meituan down 4.2% and Tencent down 3.3%, reflecting a trend of short selling across these companies.
Constituents on the Move: Several constituents saw significant price changes, including Sino Biopharma and Hansoh Pharma, which dropped 6.6% and 6.4% respectively, while WH Group rose by 4.4%, reaching a new high.
Other Notable Stocks: Stocks such as MIRXES-B and CTG Duty-Free faced substantial losses, with MIRXES-B down 21.7%, while KB Laminates and CNBM saw gains of 12.4% and 10.5%, respectively, also hitting new highs.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
<Midday Update> HSI Falls 523 Points; HSTI Declines 127 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, SINOPHARM, KB LAMINATES Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 523 points (1.9%) to 26,558, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.4% and 2.1%, respectively.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and Alibaba saw significant drops, with Meituan down 4.8% and Tencent down 3.4%, amidst high short selling ratios.
Notable Declines in Constituents: Several constituents, including Hansoh Pharma and Sino Biopharma, reported steep declines, with Hansoh Pharma down 6.5% and Sino Biopharma down 6.1%.
Gainers Amidst Losses: Despite the overall market downturn, a few stocks like WH Group and Henderson Land recorded gains, with WH Group up 3.2% and Henderson Land up 1.7%, both hitting new highs.
<Study>UBS Ratings and Price Targets for Pharmaceutical Companies (Table)
Stock Performance: Several pharmaceutical stocks showed mixed performance, with HENGRUI PHARMA and HANSOH PHARMA experiencing gains, while SINO BIOPHARM saw a decline.
Short Selling Data: Short selling activity varied across companies, with SINO BIOPHARM having the highest short selling amount at $180.02M and a ratio of 40.682%.
Target Prices: Analysts have set target prices for various stocks, with HENGRUI PHARMA and HANSOH PHARMA rated as "Buy" with target prices of HK$98.3 and HK$51.5, respectively.
Market Sentiment: CSPC PHARMA received a "Neutral" rating, indicating a more cautious outlook compared to the "Buy" ratings for other companies listed.
HSI Closes Down 384 Points on Futures Settlement Day; Declines in Tech, Auto, Consumer, and Pharma Sectors
Hong Kong Stock Market Performance: The Hong Kong stock market opened higher but closed lower, with the HSI down 384 points (1.4%) at 26,381, and total market turnover at HKD259.277 billion.
CKI Holdings' Stock Surge: A consortium led by CKI Holdings sold UKPN, resulting in a 4.5% increase in its stock price, while CKH Holdings and Power Assets also saw significant gains.
Tech Sector Declines: Alibaba's stock fell 3.6% after a report predicted weak quarterly profits, while other tech stocks like Tencent and Meituan also experienced declines.
Pharmaceuticals and Consumer Stocks Drop: Various pharmaceutical and consumer stocks saw significant losses, with declines ranging from 3.3% to 9.2% across multiple companies.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
<Full-day Summary> HSI Falls by 491 Points; HSTI Declines by 114 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, MTR CORPORATION, SINOPHARM Reach New Peaks; Market Turnover Increases
Market Performance: The Hang Seng Index (HSI) fell by 491 points (1.8%) to close at 26,590, with significant declines also seen in the HSTI and HSCEI, which dropped 114 points (2.1%) and 189 points (2.1%) respectively, amid a market turnover of $250.99 billion.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, Alibaba, and Xiaomi experienced notable declines, with Meituan down 4.2% and Tencent down 3.3%, reflecting a trend of short selling across these companies.
Constituents on the Move: Several constituents saw significant price changes, including Sino Biopharma and Hansoh Pharma, which dropped 6.6% and 6.4% respectively, while WH Group rose by 4.4%, reaching a new high.
Other Notable Stocks: Stocks such as MIRXES-B and CTG Duty-Free faced substantial losses, with MIRXES-B down 21.7%, while KB Laminates and CNBM saw gains of 12.4% and 10.5%, respectively, also hitting new highs.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
<Midday Update> HSI Falls 523 Points; HSTI Declines 127 Points; MEITUAN, PING AN Drop Over 4%; TENCENT Decreases Over 3%; WH GROUP, HENDERSON LAND, CKI HOLDINGS, SINOPHARM, KB LAMINATES Reach New Peaks
Market Performance: The Hang Seng Index (HSI) fell by 523 points (1.9%) to 26,558, while the Hang Seng Tech Index (HSTI) and the Hang Seng China Enterprises Index (HSCEI) also experienced declines of 2.4% and 2.1%, respectively.
Active Heavyweights: Major stocks like Meituan, Ping An, Tencent, and Alibaba saw significant drops, with Meituan down 4.8% and Tencent down 3.4%, amidst high short selling ratios.
Notable Declines in Constituents: Several constituents, including Hansoh Pharma and Sino Biopharma, reported steep declines, with Hansoh Pharma down 6.5% and Sino Biopharma down 6.1%.
Gainers Amidst Losses: Despite the overall market downturn, a few stocks like WH Group and Henderson Land recorded gains, with WH Group up 3.2% and Henderson Land up 1.7%, both hitting new highs.
